Skip to main content
Log in

Blood plasma proteins modulate the broncholytic effects of a muscarinic receptor antagonist

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Blood plasma proteins modulated the effects of muscarinic receptor antagonist methacin. Administration of methacin in combination with albumin or C-reactive protein (but not with IgG) abolished the broncholytic effect of methacin. It was probably associated with allosteric antagonism to M2 cholinergic receptors on non-nervous cells, which increased antibody production and mediator response. The concentration of serotonin in mesenteric lymph nodes was high during shock.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. I. S. Gushchin, Immunologiya, No. 4, 8–9 (1994).

  2. M. D. Mashkovskii, Pharmaceuticals [in Russian], Moscow (2001).

  3. P. G. Nazarov, I. B. Krylova, N. R. Evdokimova, et al., Tsitokiny Vospalenie, 5, No. 4, 32–35 (2006).

    Google Scholar 

  4. G. I. Nezhinskaya, N. A. Losev, and N. S. Sapronov, Eksper. Klin. Farmakol., 69, No. 6, 63–67 (2006).

    CAS  Google Scholar 

  5. R. M. Khaitov, I. S. Gushchin, B. V. Pinegin, et al., Manual on Experimental (Preclinical) Study of New Pharmacological Substances [in Russian], Ed. V. P. Fisenko, Moscow (2000), pp. 257–263.

  6. J. Garcia-Colunga and R. Miledi, Exp. Physiol., 84, No. 5, 847–864 (1999).

    Article  PubMed  CAS  Google Scholar 

  7. U. Kragh-Hansen, V. T. Chuang, and M. Otagiri, Biol. Pharm. Bull., 25, No. 6, 695–704 (2002).

    Article  PubMed  CAS  Google Scholar 

  8. B. M. Liederer and R. T. Borchardt, J. Pharm. Sci., 95, No. 6, 1177–1195 (2006).

    Article  PubMed  CAS  Google Scholar 

  9. A. Mizoguchi and A. K. Bhan, J. Immunol., 176, No. 2, 705–710 (2006).

    PubMed  CAS  Google Scholar 

  10. H. Rogausch, A. del Rey, A. Kabiersch, and H. O. Besedovsky, Am. J. Physiol., 268, No. 4, Pt. 2, R902–R908 (1995).

    PubMed  CAS  Google Scholar 

  11. K. Z. Sato, T. Fujii, J. Watanabe, et al., Neurosci. Lett., 266, No. 1, 17–20 (1999).

    Article  PubMed  CAS  Google Scholar 

  12. R. T. Strait, S. C. Morris, and F. D. Finkelman, J. Clin. Invest., 116, No. 3, 833–841 (2006).

    Article  PubMed  CAS  Google Scholar 

  13. I. Wessler, H. Kilbinger, F. Bittinger, et al., Life Sci., 72, Nos. 18–19, 2055–2061 (2003).

    Article  PubMed  CAS  Google Scholar 

  14. G. B. Yang and A. A. Lackner, J. Neuroimmunol., 146, Nos. 1–2, 46–49 (2004).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. I. Nezhinskaya.

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 145, No. 1, pp. 61–63, January, 2008

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nezhinskaya, G.I., Vladykin, A.L. & Sapronov, N.S. Blood plasma proteins modulate the broncholytic effects of a muscarinic receptor antagonist. Bull Exp Biol Med 145, 55–57 (2008). https://doi.org/10.1007/s10517-008-0008-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-008-0008-7

Key Words

Navigation